Drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a team of investigators led by a Yale Cancer Center scientist has found. The study was published today in the journal The Public Library of Science One.
Shape Memory Medical recently announced FDA clearance for U.S. marketing of their IMPEDE Embolization Plug, a technology funded by NIBIB and created to block irregular blood vessels.
A research team led by Duke Cancer Institute scientists has found that this blood cancer infiltrates the central nervous system not by breaching the blood-brain barrier, but by evading the barrier altogether.
By some estimates, 18 million people die each year from sepsis triggered by endotoxins – fragments of the outer membranes of bacteria. A biochemical engineer at Missouri University of Science and Technology has patented a method of removing these harmful elements from water and also from pharmaceutical formulations.Her goal: improve drug safety and increase access to clean drinking water in the developing world.
EKF Diagnostics, the global in vitro diagnostics company, announces U.S. Food and Drug Administration 510(k) clearance and CLIA waiver for the Company’s hand-held, reagent-free hemoglobin analyzer, the DiaSpect Tm. The device is cleared for use in point of care (POC) and Certificate of Waiver settings, such as physicians’ offices, clinics and other non-traditional laboratory locations.
Bloodstream infections can be life-threatening to individuals undergoing kidney dialysis. Following infection control procedures is critical, yet best practices may not always occur at busy dialysis facilities.
If a hepatitis C vaccine were successfully developed, it would dramatically reduce transmission of hepatitis C among drug users. even if the vaccine did not provide complete immunity, according to a study published in Science Translational Medicine.
Researchers discover new clues about a recently identified blood cell condition known as clonal hematopoiesis, implicated in hematologic cancers, cardiovascular illness Surprisingly, the study reveals that inherited genetic variants can drive the condition by fueling additional mutations later in life The findings can help inform ways to gauge disease risk based on specific mutations, develop strategies to avert disease Clonal hematopoiesis is estimated to affect more than 1 in 10 people older than 65
XaTek Inc., a Cleveland-based company developing a portable sensing system that can quickly assess the clotting ability of a person’s blood, recently raised $9.1 million in Series A capital to further advance and test the device, called ClotChip.
Two years after inventing a microfluidic chip believed to help detect a life-threatening blood infection, researchers in the Texas Tech University Department of Chemistry & Biochemistry and the Texas Tech University Health Sciences Center are finally seeing their product work successfully for human patients.
Using genome editing to inactivate a protein called PCSK9 effectively reduces cholesterol levels in rhesus macaques, the first demonstration of a clinically relevant reduction of gene expression in a large animal model using genome editing. This finding could lead to a possible new approach for treating heart disease patients who do not tolerate PCSK9 inhibitors—drugs that are commonly used to combat high cholesterol.
An international team of leukemia scientists has discovered how to predict healthy individuals at risk of developing acute myeloid leukemia (AML), an aggressive and often deadly blood cancer.
Research led by Washington University School of Medicine in St. Louis has shown, in mice, that genetic material can be delivered to damaged cells in the kidneys, a key step toward developing gene therapy to treat chronic kidney disease. The potentially fatal condition affects 30 million Americans, most of whom don’t realize they have chronic kidney disease.
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have found that the cost for the 10 “highest spend” medications in Medicare Part D — the U.S. federal government’s primary prescription drug benefit for older citizens — rose almost one-third between 2011 and 2015, even as the number of persons using these drugs dropped by the same amount.
A study in the American Journal of Critical Care finds that a scoring system based on the PIRO concept was useful in predicting mortality in surgical intensive care patients with severe sepsis or septic shock due to an intra-abdominal source.
Researchers develop a simple and efficient method to induce human pluripotent stem cells to become blood, which could be key in future treatments for blood disorders, immune deficiencies and cancer
Infection with the hepatitis C virus (HCV) is a contagious liver disease with symptoms that range from mild illness for a few weeks to serious, lifelong liver problems. Veterans with HCV infection are almost three times as likely to have an alcohol use disorder (AUD) than veterans without HCV. It is not well understood how the dual occurrence of HCV infection and an AUD impacts a person’s immune system, mood, and brain function. This study investigated how a co-existing AUD contributes to inflammation and psychiatric problems in adults with HCV.
Loyola Medicine neurologist José Biller, MD, is co-editor of an authoritative new textbook on uncommon causes of stroke. "Uncommon Causes of Stroke" is a comprehensive guide for healthcare professionals diagnosing, treating and assessing complex causes of strokes and other cerebrovascular disorders.
For women, even mild sleep problems can raise blood pressure, finds study.
Actinium-225 is a promising isotope for cancer treatment. Only a few places in the world can produce an extremely limited supply of it. Recently, researchers at the Department of Energy’s national laboratories have collaborated to use particle accelerators to expand this isotope’s availability.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right